Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice
- 17 March 1988
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 39 (2) , 217-223
- https://doi.org/10.1016/0304-3835(88)90107-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in miceEuropean Journal of Cancer and Clinical Oncology, 1987
- THE ANTITUMOR POTENCY OF ORAL TEGAFUR AGAINST ADENOCARCINOMA-755 IN MICE IS MARKEDLY ENHANCED BY ORAL (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE1987
- Enhancing effect of bromovinyldeoxyuridine on antitumour activity of 5-fluorouracil in mice bearing MOPC-315 plasmacytomasBritish Journal of Cancer, 1986
- EFFECT OF (E)-5-(2-BROMOVINYL)URACIL ON THE CATABOLISM AND ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL IN RATS AND LEUKEMIC MICE1986
- Schedule-Dependent Cytotoxicity of 5-Fluorouracil in Mice2JNCI Journal of the National Cancer Institute, 1986
- Inhibition of the degradation of thymine and 5-substituted uracil analogues by (E)-5-(2-bromovinyl)uracil in vivoBiochemical Pharmacology, 1985
- Cancer Chemotherapy: Alternative Routes of Drug Administration. A ReviewCancer Drug Delivery, 1985
- Continuous infusion chemotherapy: a critical review.Journal of Clinical Oncology, 1984
- Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulationsAnnals of Biomedical Engineering, 1976